| Multicenter evaluation of vancomycin dosing: emphasis on obesity RG Hall, KD Payne, AM Bain, AP Rahman, ST Nguyen, SA Eaton, ... The American journal of medicine 121 (6), 515-518, 2008 | 84 | 2008 |
| Dosing of antifungal agents in obese people KD Payne, RG Hall Expert review of anti-infective therapy 14 (2), 257-267, 2016 | 39 | 2016 |
| Dosing of antibacterial agents in obese adults: does one size fit all? KD Payne, RG Hall Expert review of anti-infective therapy 12 (7), 829-854, 2014 | 36 | 2014 |
| Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus ST Nguyen, SA Eaton, AM Bain, AP Rahman, KD Payne, R Bedimo, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (3 …, 2008 | 34 | 2008 |
| A standardized patient counseling rubric for a pharmaceutical care and communications course N Horton, KD Payne, M Jernigan, J Frost, S Wise, M Klein, J Epps, ... American journal of pharmaceutical education 77 (7), 152, 2013 | 30 | 2013 |
| Safety and Efficacy of Simvastatin for the Treatment of Dyslipidemia in Human Immunodeficiency Virus‐Infected Patients Receiving Efavirenz‐Based Highly Active Antiretroviral … AP Rahman, SA Eaton, ST Nguyen, AM Bain, KD Payne, R Bedimo, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (7 …, 2008 | 21 | 2008 |
| Multi-state medication take back initiative: Controlled substances collected from 2011 to 2015 JE Jaramillo-Stametz, H Stewart, L Ochs, K Payne Journal of Substance Use 23 (1), 36-42, 2018 | 10 | 2018 |
| Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options) KD Payne, A Das, M Ndiulor, RG Hall 2nd Expert review of clinical pharmacology 11 (2), 139-149, 2018 | 3 | 2018 |
| Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options) RG Hall 2nd, M Thatcher, W Wei, S Varghese, L Varughese, M Ndiulor, ... Expert Review of Clinical Pharmacology 10 (5), 493-508, 2017 | 3 | 2017 |
| Efficacy of pravastatin in non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI)-based HAART in HIV-infected patients SA Eaton, AP Rahman, ST Nguyen, AM Bain, KD Payne, AJ Busti American Journal of Infectious Diseases 4 (2), 124-130, 2008 | 3 | 2008 |
| Inside our medicine cabinets: Results from a multi-state medication take back initiative L Ochs, J Jaramillo, H Stewart, K Payne APHA 2017 Annual Meeting & Expo (Nov. 4-Nov. 8), 2017 | | 2017 |
| The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients AM Bain, KD Payne, AP Rahman, R Bedimo, DO Maclayton, ... American Journal of Infectious Diseases 4 (2), 147, 2008 | | 2008 |
| 103: A Multi-center Retrospective Study of the Lipid-lowering Efficacy and Safety of Switching Within the NNRTI Class in HIV-infected Patients A Bain, KD Payne, AP Rahman, R Bedimo, DO Maclayton, ... Journal of Clinical Lipidology 1 (2), 149, 2007 | | 2007 |
| 110: A Retrospective Study Evaluating the Safety and Efficacy of Simvastatin in Treating Hyperlipidemia in HIV-infected Patients on Efavirenz Based HAART AP Rahman, K Payne, A Bain, S Nguyen, S Eaton, A Busti, R Bedimo Journal of Clinical Lipidology 1 (2), 153, 2007 | | 2007 |
| 109: A Multi-Center Retrospective Study on the Clinical Efficacy and Safety on Lipid Lowering Effects After a Switch to Atazanavir/Ritonavir Based HAART ST Nguyen, SA Eaton, AJ Busti, A Bain, K Payne, A Rahman, R Bedimo, ... Journal of Clinical Lipidology 1 (2), 152-153, 2007 | | 2007 |
| 107: The Efficacy of Pravastatin in Non-neucleoside Reverse Transcriptase Inhibitor (NNRTI) and Protease Inhibitor (PI)-based HAART in HIV-infected Patients SA Eaton, ST Nguyen, AP Rahman, AM Bain, KD Payne, AJ Busti Journal of Clinical Lipidology 1 (2), 151-152, 2007 | | 2007 |
